Oppenheimer & Co »

Lucid Diagnostics shares owned by Oppenheimer & Co

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Oppenheimer & Co from 13F filings

Historical chart of Oppenheimer & Co investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by Oppenheimer & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $35k 30k 1.15

More positions owned by Oppenheimer & Co

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
Costco Wholesale Corporation (COST)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)

View all positions for Oppenheimer & Co

Top funds holding Lucid Diagnostics

Vanguard Group
BlackRock
Vanguard Capital Management
Masters Capital Mgmt
Standard Life Aberdeen
Two Seas Capital
Geode Capital Management
Russell Investments
State Street Corporation
Wells Fargo & Company
Perkins Capital Management
Sunbelt Securities
Renaissance Technologies
Northern Trust
Vanguard Fiduciary Trust

View all funds holding Lucid Diagnostics